Inspec

Inspec Revenue per Share

The Revenue per Share of Inspec (6656.T) as of Oct 23, 2026 is 617.76 JPY. In the previous year, Revenue per Share was 557.69 JPY — a change of 10.77% (higher).

Revenue per Share

617.76JPY

YoY

10.77%

Last updated:

Revenue per Share of Inspec is 2026 617.76 JPY. Revenue per Share of Inspec was 2025 557.69 JPY. It decreases by 10.77% higher compared to the previous year.

The Inspec Revenue per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
Date
Revenue per Share
Jan 1, 2020
496.83 JPY
Jan 1, 2021
323.13 JPY
Jan 1, 2022
443.69 JPY
Jan 1, 2023
571.67 JPY
Jan 1, 2024
416.18 JPY
Jan 1, 2025
557.69 JPY
Jan 1, 2026
617.76 JPY
Jan 1, 2027 (e)
0.00 JPY
The Inspec Revenue per Share history
YEARRevenue per ShareYoY
est0.00JPY-100.00%
617.76JPY+10.77%
557.69JPY+34.00%
416.18JPY-27.20%
571.67JPY+28.84%
443.69JPY+37.31%
323.13JPY-34.96%
496.83JPY-42.32%
861.28JPY+48.56%
579.76JPY-12.49%
662.48JPY+6.02%
624.84JPY+1.06%
618.26JPY+60.81%
384.47JPY-2.10%
392.73JPY-23.46%
513.11JPY-26.31%
696.34JPY+33.78%
520.49JPY+4.72%
497.05JPY-74.26%
1,930.98JPY+243.77%
561.70JPY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Inspec Stock analysis

What does Inspec do? inspec Inc. generates revenue through three primary segments. The Semiconductor Package Substrates and Precision Substrate Inspection Equipment segment sells appearance inspection equipment for semiconductor package substrates and precision printed circuit boards used in smartphones, tablets, PCs, and wearable terminals. The Precision Substrate Manufacturing Equipment segment provides photoplotters, inkjet printers, and direct imaging devices along with maintenance services for printed circuit boards. The Digital Pathology Related Equipment segment develops and sells medical image processing systems, specifically whole slide imaging (WSI) for digital pathology applications. Customers include manufacturers of advanced digital devices requiring semiconductor inspection, PCB producers needing photoplotters and imaging devices, and healthcare providers utilizing whole slide imaging systems for pathology diagnostics. The company's products target the semiconductor, electronics manufacturing, and medical imaging sectors with specific applications in device assembly, PCB production, and medical diagnostics. inspec Inc. focuses on equipment for semiconductor package substrates, precision substrates, and digital pathology, serving clients in the electronics and healthcare industries. The firm's inspection and imaging solutions are tailored to meet the quality control needs of high-tech manufacturing and medical diagnostics, with no mention of additional revenue streams beyond these three segments. Inspec is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Inspec stock

Revenue per Share of Inspec is 617.76 JPY in 2026.

Revenue per Share of Inspec changed from 557.69 JPY to 617.76 JPY, representing a 10.77% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Revenue per Share Inspec since 2006 – with annual values, charts, and detailed analysis.

Revenue per Share divides total revenue by shares outstanding, showing how much revenue each share represents.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Inspec

All Key Metrics — Inspec